Cited In for PMID: 2101470

Year	Number of Results
1990	1
1992	3
1993	1
1995	1
1998	2
1999	1
2011	1
2012	1
2019	1
2021	1
2024	0

1

Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.

Levine MM, Hone D, Tacket C, Ferreccio C, Cryz S. Levine MM, et al. Res Microbiol. 1990 Sep-Oct;141(7-8):807-16. doi: 10.1016/0923-2508(90)90114-6. Res Microbiol. 1990. PMID: 2101470 Free article. Review.

2

Salmonella Vaccine Vector System for Foot-and-Mouth Disease Virus and Evaluation of Its Efficacy with Virus-Like Particles.

Zhi Y, Ji HJ, Guo H, Lim JH, Byun EB, Kim WS, Seo HS. Zhi Y, et al. Vaccines (Basel). 2021 Jan 5;9(1):22. doi: 10.3390/vaccines9010022. Vaccines (Basel). 2021. PMID: 33466461 Free PMC article.

3

Genome-wide Analysis of Salmonella enterica serovar Typhi in Humanized Mice Reveals Key Virulence Features.

Karlinsey JE, Stepien TA, Mayho M, Singletary LA, Bingham-Ramos LK, Brehm MA, Greiner DL, Shultz LD, Gallagher LA, Bawn M, Kingsley RA, Libby SJ, Fang FC. Karlinsey JE, et al. Cell Host Microbe. 2019 Sep 11;26(3):426-434.e6. doi: 10.1016/j.chom.2019.08.001. Epub 2019 Aug 22. Cell Host Microbe. 2019. PMID: 31447308 Free PMC article.

4

Microneedle and mucosal delivery of influenza vaccines.

Kang SM, Song JM, Kim YC. Kang SM, et al. Expert Rev Vaccines. 2012 May;11(5):547-60. doi: 10.1586/erv.12.25. Expert Rev Vaccines. 2012. PMID: 22697052 Free PMC article. Review.

5

Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi.

Lindow JC, Fimlaid KA, Bunn JY, Kirkpatrick BD. Lindow JC, et al. Infect Immun. 2011 Aug;79(8):3188-94. doi: 10.1128/IAI.05081-11. Epub 2011 May 31. Infect Immun. 2011. PMID: 21628517 Free PMC article. Clinical Trial.

6

Bivalent cholera and typhoid vaccine.

Foster RH, Noble S. Foster RH, et al. Drugs. 1999 Jul;58(1):91-6; discussion 97-8. doi: 10.2165/00003495-199958010-00012. Drugs. 1999. PMID: 10439932 Review.

7

Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than a prototypical aroA mutant.

Valentine PJ, Devore BP, Heffron F. Valentine PJ, et al. Infect Immun. 1998 Jul;66(7):3378-83. doi: 10.1128/IAI.66.7.3378-3383.1998. Infect Immun. 1998. PMID: 9632608 Free PMC article.

8

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.

Corthésy-Theulaz IE, Hopkins S, Bachmann D, Saldinger PF, Porta N, Haas R, Zheng-Xin Y, Meyer T, Bouzourène H, Blum AL, Kraehenbuhl JP. Corthésy-Theulaz IE, et al. Infect Immun. 1998 Feb;66(2):581-6. doi: 10.1128/IAI.66.2.581-586.1998. Infect Immun. 1998. PMID: 9453612 Free PMC article.

9

Acid resistance in enteric bacteria.

Gorden J, Small PL. Gorden J, et al. Infect Immun. 1993 Jan;61(1):364-7. doi: 10.1128/iai.61.1.364-367.1993. Infect Immun. 1993. PMID: 8418063 Free PMC article.

10

Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Shroff KE, Meslin K, Cebra JJ. Shroff KE, et al. Infect Immun. 1995 Oct;63(10):3904-13. doi: 10.1128/iai.63.10.3904-3913.1995. Infect Immun. 1995. PMID: 7558298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year